Abstract

Health care needs to continuously evolve and innovate to maintain the health of populations. Technology has the potential to enable better patient engagement and ownership, as well as optimise therapeutic interventions and data-science approaches to facilitate improved health care decisions. Yet, to date, technological innovation has not resulted in the rate of change that could have been predicted from other sectors. This article discusses multiple reasons for this and proposes a newly tested and deployed solution: the technology clinical trial. The technology clinical trial methodology has been developed through working directly with patients, clinical and medical devicetrial experts. This approach enables researchers to use the complex environment of health care as an opportunity to transform the pace of innovation and create new care pathways. Instead of testing a single innovation, researchers can ‘step back’ and systematically review all areas of the patient's journey for potential optimization. Then integrate novel data science, technological advances, process updates, behavioural science, and patient engagement to co-create a streamlined multidisciplinary solution. As a result, this research has the potential for larger advances due to the emergent benefits that can arise when the individual elements work together as a whole. These potential benefits are then robustly tested, characterised and measured in the trial environment to ensure that future application of the innovative pathway is supported by the robust empirical data health care requires.

Highlights

  • Health has a direct impact on both the economy and each person’s individual enjoyment of life

  • This paper identifies four key elements that underpin all current care pathways and must be addressed by research for future innovation to robustly realise its potential:

  • This article aims to share this novel methodology with other research groups to support broader adoption of objective care-pathway assessment through the application of technology clinical trials

Read more

Summary

Introduction

Health has a direct impact on both the economy and each person’s individual enjoyment of life. Countries around the world are facing the monumental problem of maintaining the health of aging populations through either prevention or treatment of disease. Clinical Trials of Investigational Medicinal Products (CTIMPs) test new drugs and ensure that they provide acceptable gains in benefits, and reductions in risks, when compared with existing options. Health care is the point where clinical-science meets people – and it is usually people who decide how, and whether, they will accept the proposed therapeutic intervention.

Objectives
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call